Vertex Pharmaceuticals Inc. closed 18.39% short of its 52-week high of $519.88, which the company reached on November 8th.
Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback